# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-010817
Filing Date
2024-03-21
Accepted
2024-03-21 17:25:31
Documents
4
Period of Report
2024-03-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 661986
2 |  | formdef14a_001.jpg | GRAPHIC | 5591
3 |  | proxy_001.jpg | GRAPHIC | 391881
4 |  | proxy_002.jpg | GRAPHIC | 79462
| Complete submission text file | 0001493152-24-010817.txt |  | 1320379

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41210 | Film No.: 24772430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)